Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Beta Bionics has announced the pricing of its upsized initial public offering of 12 million shares of common stock at a price to the public of $17 per share.

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

The company, which makes medical devices and also sells nutrition products such as baby formula, has seen a large boost to sales from strong demand for FreeStyle Libre ... rose 1.3%, reversing ...

Abbott has won an innovation award for Lingo, its first consumer biowearable over-the-counter device to empower people in improving overall health and wellness.

“Tidy dynamics and an upmarket cabin make the Mazda 3 a top-notch hatch, even if it is a bit poky” Mazda is into simplicity, on the whole. Just two petrol engines are available: a 2.5-litre ...

The event, held in Nendaz, Switzerland, combines big mountain powder skiing with backcountry freestyle. In plain English—the event organizers selected a rolling off-piste run, peppering it with ...

One lucky reader will win a pair of tickets to see Cinderella at the venue of their choice, plus an overnight stay with evening meal at a Premier Inn hotel (premierinn.com), with breakfast in the ...

Omnipod 5 is available with both Abbott’s FreeStyle Libre 2 Plus and Dexcom G6 Continuous Glucose Monitoring (“CGM”) sensor compatibility. The latest development represents a significant ...